ABVC BioPharma, Inc. Common Stock (NASDAQ: ABVC) last traded at $0.890, down 1.11% on the session. The quote above updates while this page is open; the figures below are drawn from ABVC BioPharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
ABVC BioPharma, Inc. Common Stock trades on NASDAQ under the ticker ABVC. Its market capitalisation is $23.72 million.
Valuation measures for ABVC BioPharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $23.72M |
|---|---|
| Enterprise value | $30.82M |
| Price / sales | 80.13 |
| Price / book | 2.31 |
| Beta | 1.61 |
Trailing-twelve-month figures tagged in ABVC BioPharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $296.0K |
|---|---|
| Net income (TTM) | -$7.11M |
| EPS (TTM) | -$0.290 |
| Operating margin | -2201.10% |
| Return on equity | -69.08% |
| Cash | $31.9K |
Range and volume for ABVC over the past 52 weeks.
| 52-week high | $3.40 |
|---|---|
| 52-week low | $0.821 |
| Volume | 56.8K |
| Average volume | 145.4K |
| Previous close | $0.900 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.